Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101
Conclusion.Although paclitaxel‐induced neuropathy is common, older age is not an independent risk factor. Clinical trial identification number. NCT00041119 (CALGB 40101).Implications for Practice.Age alone is not an independent risk factor for paclitaxel‐induced neuropathy.
Source: The Oncologist - Category: Cancer & Oncology Authors: Myra Barginear, Amylou C. Dueck, Jacob B. Allred, Craig Bunnell, Harvey J. Cohen, Rachel A. Freedman, Arti Hurria, Gretchen Kimmick, Jennifer G. Le-Rademacher, Stuart Lichtman, Hyman B. Muss, Lawrence N. Shulman, M. Sitiki Copur, David Biggs, Bhuvaneswari Tags: Breast Cancer, Geriatric Oncology Source Type: research
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Eating Disorders & Weight Management | Geriatrics | Legislation | Leukemia | Neurology | Obesity | Statistics | Study | Women